Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Outline of Final Research Achievements |
Chronic kidney disease (CKD) is one of the most prevalent diseases and leading to the necessity of renal replacement therapy, whose novel therapeutic stratedy is eagerly awaited. We have previously reported the role of chronic inflammation in CKD as well as diabetic nephropathy. In this study, we investigated the role of MRP8, one of the inflammatory endogenous ligands, in the crescentic glomerulonephritis. Our results suggested that ablation of MRP8 in myeloid cells ameliorated crescentic glomerulonephritis through affecting macrophage polarity.MRP8 could become as a theraputic target in glomerulonephritis.
|